Provided by Tiger Trade Technology Pte. Ltd.

Xeris Pharmaceuticals Inc

10.48
+0.29002.85%
Post-market: 10.480.00000.00%19:30 EDT
Volume:3.00M
Turnover:31.27M
Market Cap:1.91B
PE:-102.74
High:10.60
Open:10.15
Low:10.07
Close:10.19
52wk High:11.33
52wk Low:5.25
Shares:182.32M
Float Shares:172.57M
Volume Ratio:1.15
T/O Rate:1.74%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1020
EPS(LYR):0.0032
ROE:-617.16%
ROA:6.13%
PB:-196.29
PE(LYR):3,267.85

Loading ...

Xeris Biopharma Holdings (XERS) After Record Quarter And Debt Retirement Still Looks Undervalued

Simply Wall St.
·
Yesterday

Xeris Biopharma is Maintained at Overweight by Barclays

Dow Jones
·
Oct 06

Xeris Biopharma price target raised to $14 from $12 at Barclays

TIPRANKS
·
Oct 06

Analysts Offer Insights on Healthcare Companies: Establishment Labs Holdings (ESTA), Xeris Pharmaceuticals (XERS) and Incyte (INCY)

TIPRANKS
·
Oct 06

Xeris Biopharma Grants Inducement Equity Awards Covering 352,170 Shares to 60 New Employees

Reuters
·
Oct 03

Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Oct 03

Xeris Biopharma Chief Legal Officer Beth Hecht Disposes of 16,666 Shares Worth $156,797

Reuters
·
Oct 03

Deals of the Day-Mergers and Acquisitions

Reuters
·
Sep 30

Xeris Biopharma COO Kevin McCulloch Sells $250,000 in Common Shares

Reuters
·
Sep 30

Xeris Biopharma Rises on Report of Lundbeck Takeover Interest

Reuters
·
Sep 30

Lundbeck exploring acquisition of Xeris, Bloomberg reports

TIPRANKS
·
Sep 30

Lundbeck is Said to Express Interest in Buying Xeris Biopharma - Bloomberg News

THOMSON REUTERS
·
Sep 30

Market Chatter: Lundbeck Said to Explore Potential Xeris Biopharma Acquisition

MT Newswires Live
·
Sep 30

Xeris Biopharma tells Bloomberg ‘not for sale’

TIPRANKS
·
Sep 30

Lundbeck Said to Explore Potential Xeris Biopharma Acquisition, Bloomberg Reports

MT Newswires Live
·
Sep 30

H.C. Wainwright Remains a Buy on Xeris Pharmaceuticals (XERS)

TIPRANKS
·
Sep 22

Xeris Biopharma is Maintained at Outperform by Leerink Partners

Dow Jones
·
Sep 10

Analysts Conflicted on These Healthcare Names: Xeris Pharmaceuticals (XERS) and Pharvaris (PHVS)

TIPRANKS
·
Sep 10

Xeris Biopharma price target raised to $16 from $12 at Leerink

TIPRANKS
·
Sep 10

Medmix Drug Delivery Unit Partners with Xeris on XP-8121 D-Flex Pen Injector Development

Reuters
·
Sep 10